OPKO Health Total Liabilities 2010-2024 | OPK

OPKO Health total liabilities from 2010 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.
OPKO Health Annual Total Liabilities
(Millions of US $)
2023 $622
2022 $606
2021 $715
2020 $802
2019 $695
2018 $660
2017 $746
2016 $675
2015 $819
2014 $432
2013 $519
2012 $111
2011 $69
2010 $55
2009 $56
OPKO Health Quarterly Total Liabilities
(Millions of US $)
2024-03-31 $721
2023-12-31 $622
2023-09-30 $612
2023-06-30 $624
2023-03-31 $618
2022-12-31 $606
2022-09-30 $596
2022-06-30 $651
2022-03-31 $692
2021-12-31 $715
2021-09-30 $652
2021-06-30 $679
2021-03-31 $823
2020-12-31 $802
2020-09-30 $748
2020-06-30 $735
2020-03-31 $684
2019-12-31 $695
2019-09-30 $728
2019-06-30 $747
2019-03-31 $813
2018-12-31 $660
2018-09-30 $692
2018-06-30 $720
2018-03-31 $756
2017-12-31 $746
2017-09-30 $633
2017-06-30 $662
2017-03-31 $653
2016-12-31 $675
2016-09-30 $695
2016-06-30 $758
2016-03-31 $795
2015-12-31 $819
2015-09-30 $1,046
2015-06-30 $699
2015-03-31 $700
2014-12-31 $432
2014-09-30 $408
2014-06-30 $414
2014-03-31 $524
2013-12-31 $519
2013-09-30 $515
2013-06-30 $329
2013-03-31 $334
2012-12-31 $111
2012-09-30 $104
2012-06-30 $79
2012-03-31 $77
2011-12-31 $69
2011-09-30 $49
2011-06-30 $49
2011-03-31 $53
2010-12-31 $55
2010-09-30 $48
2010-06-30 $18
2010-03-31 $31
2009-12-31 $56
2009-09-30 $19
2009-06-30 $21
2009-03-31 $27
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.878B $0.864B
OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $217.261B 26.33
Intuitive Surgical (ISRG) United States $154.295B 92.95
Edwards Lifesciences (EW) United States $53.342B 34.71
DexCom (DXCM) United States $46.386B 70.26
Alcon (ALC) Switzerland $44.049B 31.57
IDEXX Laboratories (IDXX) United States $41.591B 48.75
IQVIA Holdings (IQV) United States $38.778B 22.50
STERIS (STE) Ireland $21.402B 25.00
SONOVA HOLDING (SONVY) Switzerland $18.282B 0.00
Waters (WAT) United States $17.464B 25.67
Hologic (HOLX) United States $16.679B 18.66
Fresenius Medical Care AG KGaA (FMS) Germany $11.531B 13.46
Sysmex ADR (SSMXY) Japan $9.982B 31.30
Teleflex (TFX) United States $9.519B 14.82
Globus Medical (GMED) United States $9.073B 26.59
Masimo (MASI) United States $7.222B 41.53
Penumbra (PEN) United States $6.824B 77.55
Glaukos (GKOS) United States $5.711B 0.00
TransMedics (TMDX) United States $4.808B 456.12
Integer Holdings (ITGR) United States $3.854B 23.28
PROCEPT BioRobotics (PRCT) United States $3.188B 0.00
LivaNova (LIVN) United Kingdom $2.893B 17.18
Tandem Diabetes Care (TNDM) United States $2.766B 0.00
Nihon Kohden (NHNKY) Japan $2.661B 14.09
Inari Medical (NARI) United States $2.641B 0.00
Elekta AB (EKTAY) Sweden $2.365B 18.13
Integra LifeSciences Holdings (IART) United States $2.285B 9.97
RxSight (RXST) United States $2.111B 0.00
Veracyte (VCYT) United States $1.637B 0.00
Alphatec Holdings (ATEC) United States $1.452B 0.00
Silk Road Medical (SILK) United States $1.060B 0.00
Artivion (AORT) United States $0.967B 92.76
AVANOS MEDICAL, INC (AVNS) United States $0.876B 17.05
OrthoPediatrics (KIDS) United States $0.713B 0.00
Pulse Biosciences (PLSE) United States $0.630B 0.00
IRadimed (IRMD) United States $0.536B 30.01
SiBone (SIBN) United States $0.511B 0.00
Mesa Laboratories (MLAB) United States $0.492B 14.60
ORTHOFIX MEDICAL INC (OFIX) United States $0.483B 0.00
Paragon 28 (FNA) United States $0.474B 0.00
Pacific Biosciences Of California (PACB) United States $0.448B 0.00
Treace Medical Concepts (TMCI) United States $0.374B 0.00
Nevro (NVRO) United States $0.324B 0.00
Sight Sciences (SGHT) United States $0.318B 0.00
AxoGen (AXGN) United States $0.312B 0.00
Tactile Systems Technology (TCMD) United States $0.273B 9.34
Semler Scientific (SMLR) United States $0.263B 13.35
CVRx (CVRX) United States $0.239B 0.00
AngioDynamics (ANGO) United States $0.226B 0.00
Delcath Systems (DCTH) United States $0.212B 0.00
EDAP TMS S.A (EDAP) France $0.195B 0.00
908 Devices (MASS) United States $0.189B 0.00
NeuroPace (NPCE) United States $0.187B 0.00
Inogen (INGN) United States $0.180B 0.00
Accuray (ARAY) United States $0.173B 0.00
Alpha Tau Medical (DRTS) Israel $0.155B 0.00
ClearPoint Neuro (CLPT) United States $0.144B 0.00
Atossa Genetics (ATOS) United States $0.141B 0.00
Yubo Biotech (YBGJ) China $0.129B 0.00
KORU Medical Systems (KRMD) United States $0.102B 0.00
Spectral Diagnostics (EDTXF) Canada $0.101B 0.00
Sensus Healthcare (SRTS) United States $0.085B 17.79
InspireMD (NSPR) Israel $0.068B 0.00
Monogram Orthopaedics (MGRM) United States $0.067B 0.00
EnVVeno Medical (NVNO) United States $0.063B 0.00
Hyperfine (HYPR) United States $0.060B 0.00
SEP Acquisition (SEPA) United States $0.056B 0.00
Neuronetics (STIM) United States $0.055B 0.00
LENSAR (LNSR) United States $0.050B 0.00
Envoy Medical (COCH) United States $0.048B 0.00
T2 Biosystems (TTOO) United States $0.047B 0.00
Lucid Diagnostics (LUCD) United States $0.038B 0.00
ReWalk Robotics (LFWD) Israel $0.036B 0.00
Precision Optics (POCI) United States $0.035B 0.00
Rapid Micro Biosystems (RPID) United States $0.033B 0.00
Vicarious Surgical (RBOT) United States $0.033B 0.00
DarioHealth (DRIO) United States $0.033B 0.00
Spectral AI (MDAI) United States $0.028B 0.00
Accelerate Diagnostics (AXDX) United States $0.026B 0.00
Pixie Dust Technologies (PXDT) Japan $0.022B 0.00
Autonomix Medical (AMIX) United States $0.021B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.021B 0.00
Aspira Women's Health (AWH) United States $0.020B 0.00
Ekso Bionics Holdings (EKSO) United States $0.019B 0.00
QT Imaging Holdings (QTI) United States $0.016B 0.00
Microbot Medical (MBOT) United States $0.015B 0.00
NexGel (NXGL) United States $0.014B 0.00
Check-Cap (CHEK) Israel $0.013B 0.00
PAVmed (PAVM) United States $0.009B 0.00
Venus Concept (VERO) Canada $0.006B 0.00
Nuwellis (NUWE) United States $0.004B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.004B 0.00
Avinger (AVGR) United States $0.003B 0.00
Helius Medical Technologies (HSDT) United States $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
Tenon Medical (TNON) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Dynatronics (DYNT) United States $0.002B 0.00
ENDRA Life Sciences (NDRA) United States $0.001B 0.00
Bluejay Diagnostics (BJDX) United States $0.001B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00